Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Dual anti-seizure medications, especially valproic acid with lamotrigine, often cause more side effects like hair loss and memory issues.

A girl with Pitt-Hopkins syndrome developed curly hair as a rare side effect from the epilepsy drug perampanel.

Valproic acid is an effective seizure medication with some temporary side effects.

New compounds were developed that promote hair growth in mice.

Most children with epilepsy on antiepileptic drugs experience side effects, especially those on multiple drugs, but these drugs help reduce seizures.

Trilostane may help delay epilepsy development by increasing certain brain chemicals.

CTP-543 is generally safe for treating alopecia areata.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Some birth control pills increase blood clot risk; use them for specific conditions only.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Sodium valproate reduced seizures in many patients with resistant epilepsy.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

The drug combination significantly reduced epileptic drop attacks in patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Pegvaliase is recommended for treating adults with phenylketonuria.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Valproic acid is effective for various seizures, but may cause temporary side effects like drowsiness and stomach issues.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.